Literature DB >> 10856521

A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.

T Suehiro1, T Nakamura, M Inoue, T Shiinoki, Y Ikeda, Y Kumon, M Shindo, H Tanaka, K Hashimoto.   

Abstract

Human serum paraoxonase (PON1) is an esterase that has been shown to decrease the susceptibility of lipoproteins to lipid peroxidation. We found a polymorphism of cytosine/thymidine (-108C/T, the number is from the ATG codon) in the upstream region of the PON1 gene. The luciferase activity was lower in the -108T allele than in the -108C allele. The serum PON1 concentrations in 132 normal subjects were as follows: -108CC>-108CT and>-108TT genotypes. The polymorphism upstream from the PON1 gene is associated with transcription of the PON1 gene and the serum PON1 concentration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856521     DOI: 10.1016/s0021-9150(99)00379-2

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  32 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  Human PON1, a biomarker of risk of disease and exposure.

Authors:  C E Furlong; S M Suzuki; R C Stevens; J Marsillach; R J Richter; G P Jarvik; H Checkoway; A Samii; L G Costa; A Griffith; J W Roberts; D Yearout; C P Zabetian
Journal:  Chem Biol Interact       Date:  2010-03-23       Impact factor: 5.192

3.  Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome.

Authors:  Dor Mohammad Kordi-Tamandani; Mohammad Hashemi; Nooshin Sharifi; Mahmoud Ali Kaykhaei; Adam Torkamanzehi
Journal:  Mol Biol Rep       Date:  2011-05-15       Impact factor: 2.316

4.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

5.  The regulation of hepatic Pon1 by a maternal high-fat diet is gender specific and may occur through promoter histone modifications in neonatal rats.

Authors:  Rita S Strakovsky; Xiyuan Zhang; Dan Zhou; Yuan-Xiang Pan
Journal:  J Nutr Biochem       Date:  2013-11-06       Impact factor: 6.048

Review 6.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

7.  Paraoxonase 1 (PON1) status and substrate hydrolysis.

Authors:  Rebecca J Richter; Gail P Jarvik; Clement E Furlong
Journal:  Toxicol Appl Pharmacol       Date:  2008-11-13       Impact factor: 4.219

8.  Dynamic variation in allele-specific gene expression of Paraoxonase-1 in murine and human tissues.

Authors:  Layla Parker-Katiraee; Eleni Bousiaki; David Monk; Gudrun E Moore; Kazuhiko Nakabayashi; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2008-08-04       Impact factor: 6.150

Review 9.  Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.

Authors:  Lucio G Costa; Gennaro Giordano; Toby B Cole; Judit Marsillach; Clement E Furlong
Journal:  Toxicology       Date:  2012-07-31       Impact factor: 4.221

10.  Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-exposed agricultural pesticide handlers.

Authors:  Jonathan N Hofmann; Matthew C Keifer; Clement E Furlong; Anneclaire J De Roos; Federico M Farin; Richard A Fenske; Gerald van Belle; Harvey Checkoway
Journal:  Environ Health Perspect       Date:  2009-06-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.